| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |